Kenmerk
Fluid retention
Klinische naam: Edema
An abnormal accumulation of fluid beneath the skin, or in one or more cavities of the body.
Samenvatting
- Ook bekend als
- Water retention, Dropsy, Hydrops, Oedema
- Lichaamssysteem
- Laboratory abnormality
ReferentiegenoomGRCh38hg38
Posities op gen- en variantpagina's volgen deze keuze, in deze browser.
Read the genes linked to Fluid retention, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen227 genen gekoppeld aan Fluid retention
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Fluid retention voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ALBalbumin | Altijd | In 2 aandoeningen |
| ALG8ALG8 alpha-1,3-glucosyltransferase | Altijd | In 2 aandoeningen |
| ATP7BATPase copper transporting beta | Altijd | In 1 aandoening |
| CCDC88Acoiled-coil and HOOK domain protein 88A | Altijd | In 1 aandoening |
| DCLRE1CDNA cross-link repair 1C | Altijd | In 2 aandoeningen |
| IFT140intraflagellar transport 140 | Altijd | In 1 aandoening |
| MRPS16mitochondrial ribosomal protein S16 | Altijd | In 1 aandoening |
| MYO1Emyosin IE | Altijd | In 2 aandoeningen |
| OTULINOTU deubiquitinase with linear linkage specificity | Altijd | In 1 aandoening |
| PDSS2decaprenyl diphosphate synthase subunit 2 | Altijd | In 1 aandoening |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Altijd | In 1 aandoening |
| PSMG2proteasome assembly chaperone 2 | Altijd | In 1 aandoening |
| PTPROprotein tyrosine phosphatase receptor type O | Altijd | In 2 aandoeningen |
| RAG1recombination activating 1 | Altijd | In 2 aandoeningen |
| RAG2recombination activating 2 | Altijd | In 2 aandoeningen |
| SCARB2scavenger receptor class B member 2 | Altijd | In 1 aandoening |
| SPOUT1SPOUT domain containing methyltransferase 1 | Altijd | In 1 aandoening |
| VPS51VPS51 subunit of GARP complex | Altijd | In 1 aandoening |
| ACTN4actinin alpha 4 | Heel vaak (80–99%) | In 2 aandoeningen |
| AGBL1AGBL carboxypeptidase 1 | Heel vaak (80–99%) | In 1 aandoening |
| ANKFY1ankyrin repeat and FYVE domain containing 1 | Heel vaak (80–99%) | In 1 aandoening |
| ANLNanillin, actin binding protein | Heel vaak (80–99%) | In 1 aandoening |
| APOL1apolipoprotein L1 | Heel vaak (80–99%) | In 1 aandoening |
| ARHGAP24Rho GTPase activating protein 24 | Heel vaak (80–99%) | In 1 aandoening |
| ARHGDIARho GDP dissociation inhibitor alpha | Heel vaak (80–99%) | In 2 aandoeningen |
| AVILadvillin | Heel vaak (80–99%) | In 1 aandoening |
| CD2APCD2 associated protein | Heel vaak (80–99%) | In 1 aandoening |
| CD55CD55 molecule (Cromer blood group) | Heel vaak (80–99%) | In 1 aandoening |
| COL4A3collagen type IV alpha 3 chain | Heel vaak (80–99%) | In 1 aandoening |
| COL8A2collagen type VIII alpha 2 chain | Heel vaak (80–99%) | In 1 aandoening |
| COQ8Bcoenzyme Q8B | Heel vaak (80–99%) | In 2 aandoeningen |
| CRB2crumbs cell polarity complex component 2 | Heel vaak (80–99%) | In 1 aandoening |
| DAAM2dishevelled associated activator of morphogenesis 2 | Heel vaak (80–99%) | In 1 aandoening |
| EMP2epithelial membrane protein 2 | Heel vaak (80–99%) | In 1 aandoening |
| GAPVD1GTPase activating protein and VPS9 domains 1 | Heel vaak (80–99%) | In 1 aandoening |
| INF2inverted formin 2 | Heel vaak (80–99%) | In 1 aandoening |
| KANK2KN motif and ankyrin repeat domains 2 | Heel vaak (80–99%) | In 1 aandoening |
| KRT2keratin 2 | Heel vaak (80–99%) | In 1 aandoening |
| LAMA5laminin subunit alpha 5 | Heel vaak (80–99%) | In 1 aandoening |
| MAGI2membrane associated guanylate kinase, WW and PDZ domain containing 2 | Heel vaak (80–99%) | In 1 aandoening |
Toon nog 187 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| MAPRE2microtubule associated protein RP/EB family member 2 | Heel vaak (80–99%) | In 1 aandoening |
| NPHS1NPHS1 adhesion molecule, nephrin | Heel vaak (80–99%) | In 2 aandoeningen |
| NPHS2NPHS2 stomatin family member, podocin | Heel vaak (80–99%) | In 2 aandoeningen |
| NUP107nucleoporin 107 | Heel vaak (80–99%) | In 2 aandoeningen |
| NUP133nucleoporin 133 | Heel vaak (80–99%) | In 1 aandoening |
| NUP160nucleoporin 160 | Heel vaak (80–99%) | In 1 aandoening |
| NUP205nucleoporin 205 | Heel vaak (80–99%) | In 1 aandoening |
| NUP37nucleoporin 37 | Heel vaak (80–99%) | In 1 aandoening |
| NUP85nucleoporin 85 | Heel vaak (80–99%) | In 1 aandoening |
| NUP93nucleoporin 93 | Heel vaak (80–99%) | In 1 aandoening |
| PAX2paired box 2 | Heel vaak (80–99%) | In 3 aandoeningen |
| PLCE1phospholipase C epsilon 1 | Heel vaak (80–99%) | In 2 aandoeningen |
| SLC4A11solute carrier family 4 member 11 | Heel vaak (80–99%) | In 1 aandoening |
| TBC1D8BTBC1 domain family member 8B | Heel vaak (80–99%) | In 1 aandoening |
| TCF4transcription factor 4 | Heel vaak (80–99%) | In 1 aandoening |
| TRPC6transient receptor potential cation channel subfamily C member 6 | Heel vaak (80–99%) | In 1 aandoening |
| TUBBtubulin beta class I | Heel vaak (80–99%) | In 1 aandoening |
| WT1WT1 transcription factor | Heel vaak (80–99%) | In 1 aandoening |
| ZEB1zinc finger E-box binding homeobox 1 | Heel vaak (80–99%) | In 1 aandoening |
| ABCC9ATP binding cassette subfamily C member 9 | Vaak (30–79%) | In 1 aandoening |
| ACTC1actin alpha cardiac muscle 1 | Vaak (30–79%) | In 1 aandoening |
| ACTN2actinin alpha 2 | Vaak (30–79%) | In 1 aandoening |
| ADAadenosine deaminase | Vaak (30–79%) | In 1 aandoening |
| ANKRD1ankyrin repeat domain 1 | Vaak (30–79%) | In 1 aandoening |
| BAG3BAG cochaperone 3 | Vaak (30–79%) | In 1 aandoening |
| BAG5BAG cochaperone 5 | Vaak (30–79%) | In 1 aandoening |
| CAP2cyclase associated actin cytoskeleton regulatory protein 2 | Vaak (30–79%) | In 1 aandoening |
| CHD7chromodomain helicase DNA binding protein 7 | Vaak (30–79%) | In 1 aandoening |
| COL2A1collagen type II alpha 1 chain | Vaak (30–79%) | In 2 aandoeningen |
| CRYABcrystallin alpha B | Vaak (30–79%) | In 1 aandoening |
| CSRP3cysteine and glycine rich protein 3 | Vaak (30–79%) | In 1 aandoening |
| DESdesmin | Vaak (30–79%) | In 1 aandoening |
| DGKEdiacylglycerol kinase epsilon | Vaak (30–79%) | In 1 aandoening |
| DMDdystrophin | Vaak (30–79%) | In 1 aandoening |
| DOLKdolichol kinase | Vaak (30–79%) | In 1 aandoening |
| DSG2desmoglein 2 | Vaak (30–79%) | In 1 aandoening |
| DSPdesmoplakin | Vaak (30–79%) | In 2 aandoeningen |
| FHL2four and a half LIM domains 2 | Vaak (30–79%) | In 1 aandoening |
| FKTNfukutin | Vaak (30–79%) | In 1 aandoening |
| FLNCfilamin C | Vaak (30–79%) | In 1 aandoening |
| GATAD1GATA zinc finger domain containing 1 | Vaak (30–79%) | In 1 aandoening |
| GET3guided entry of tail-anchored proteins factor 3, ATPase | Vaak (30–79%) | In 1 aandoening |
| GNA14G protein subunit alpha 14 | Vaak (30–79%) | In 1 aandoening |
| GSNgelsolin | Vaak (30–79%) | In 1 aandoening |
| HAND2heart and neural crest derivatives expressed 2 | Vaak (30–79%) | In 1 aandoening |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Vaak (30–79%) | In 1 aandoening |
| HPGD15-hydroxyprostaglandin dehydrogenase | Vaak (30–79%) | In 1 aandoening |
| IFIH1interferon induced with helicase C domain 1 | Vaak (30–79%) | In 1 aandoening |
| IL2RGinterleukin 2 receptor subunit gamma | Vaak (30–79%) | In 1 aandoening |
| IL7Rinterleukin 7 receptor | Vaak (30–79%) | In 1 aandoening |
| IRAK1interleukin 1 receptor associated kinase 1 | Vaak (30–79%) | In 1 aandoening |
| JPH2junctophilin 2 | Vaak (30–79%) | In 1 aandoening |
| KIF11kinesin family member 11 | Vaak (30–79%) | In 1 aandoening |
| LAMA4laminin subunit alpha 4 | Vaak (30–79%) | In 1 aandoening |
| LDB3LIM domain binding 3 | Vaak (30–79%) | In 1 aandoening |
| LMNAlamin A/C | Vaak (30–79%) | In 1 aandoening |
| LMOD2leiomodin 2 | Vaak (30–79%) | In 1 aandoening |
| LPIN2lipin 2 | Vaak (30–79%) | In 1 aandoening |
| MAGEL2MAGE family member L2 | Vaak (30–79%) | In 1 aandoening |
| MKRN3makorin ring finger protein 3 | Vaak (30–79%) | In 1 aandoening |
| MPImannose phosphate isomerase | Vaak (30–79%) | In 2 aandoeningen |
| MVKmevalonate kinase | Vaak (30–79%) | In 1 aandoening |
| MYBPC3myosin binding protein C3 | Vaak (30–79%) | In 1 aandoening |
| MYH6myosin heavy chain 6 | Vaak (30–79%) | In 1 aandoening |
| MYH7myosin heavy chain 7 | Vaak (30–79%) | In 1 aandoening |
| MYPNmyopalladin | Vaak (30–79%) | In 1 aandoening |
| NEU1neuraminidase 1 | Vaak (30–79%) | In 1 aandoening |
| NEXNnexilin F-actin binding protein | Vaak (30–79%) | In 1 aandoening |
| NLRP3NLR family pyrin domain containing 3 | Vaak (30–79%) | In 1 aandoening |
| NPAP1nuclear pore associated protein 1 | Vaak (30–79%) | In 1 aandoening |
| NRAPnebulin related anchoring protein | Vaak (30–79%) | In 1 aandoening |
| NUDCD3NudC domain containing 3 | Vaak (30–79%) | In 1 aandoening |
| PLNphospholamban | Vaak (30–79%) | In 1 aandoening |
| PPCSphosphopantothenoylcysteine synthetase | Vaak (30–79%) | In 1 aandoening |
| PRDM16PR/SET domain 16 | Vaak (30–79%) | In 1 aandoening |
| PRF1perforin 1 | Vaak (30–79%) | In 1 aandoening |
| PSAT1phosphoserine aminotransferase 1 | Vaak (30–79%) | In 1 aandoening |
| PSEN1presenilin 1 | Vaak (30–79%) | In 1 aandoening |
| PSEN2presenilin 2 | Vaak (30–79%) | In 1 aandoening |
| PSMB10proteasome 20S subunit beta 10 | Vaak (30–79%) | In 1 aandoening |
| PWAR1Prader Willi/Angelman region RNA 1 | Vaak (30–79%) | In 1 aandoening |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Vaak (30–79%) | In 1 aandoening |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Vaak (30–79%) | In 1 aandoening |
| RBM20RNA binding motif protein 20 | Vaak (30–79%) | In 1 aandoening |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Vaak (30–79%) | In 1 aandoening |
| RPL3Lribosomal protein L3 like | Vaak (30–79%) | In 1 aandoening |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Vaak (30–79%) | In 1 aandoening |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Vaak (30–79%) | In 1 aandoening |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Vaak (30–79%) | In 1 aandoening |
| SGCDsarcoglycan delta | Vaak (30–79%) | In 1 aandoening |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Vaak (30–79%) | In 1 aandoening |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Vaak (30–79%) | In 1 aandoening |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Vaak (30–79%) | In 1 aandoening |
| SPP1secreted phosphoprotein 1 | Vaak (30–79%) | In 1 aandoening |
| STAT4signal transducer and activator of transcription 4 | Vaak (30–79%) | In 1 aandoening |
| STX11syntaxin 11 | Vaak (30–79%) | In 1 aandoening |
| TAF1ATATA-box binding protein associated factor, RNA polymerase I subunit A | Vaak (30–79%) | In 1 aandoening |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Vaak (30–79%) | In 1 aandoening |
| TALDO1transaldolase 1 | Vaak (30–79%) | In 1 aandoening |
| TCAPtitin-cap | Vaak (30–79%) | In 1 aandoening |
| TMPOthymopoietin | Vaak (30–79%) | In 1 aandoening |
| TNNC1troponin C1, slow skeletal and cardiac type | Vaak (30–79%) | In 1 aandoening |
| TNNI3troponin I3, cardiac type | Vaak (30–79%) | In 1 aandoening |
| TNNT2troponin T2, cardiac type | Vaak (30–79%) | In 1 aandoening |
| TPM1tropomyosin 1 | Vaak (30–79%) | In 1 aandoening |
| TPRKBTP53RK binding protein | Vaak (30–79%) | In 1 aandoening |
| TTNtitin | Vaak (30–79%) | In 1 aandoening |
| TXNRD2thioredoxin reductase 2 | Vaak (30–79%) | In 1 aandoening |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Vaak (30–79%) | In 1 aandoening |
| VCLvinculin | Vaak (30–79%) | In 1 aandoening |
| VEZF1vascular endothelial zinc finger 1 | Vaak (30–79%) | In 1 aandoening |
| ABCC6ATP binding cassette subfamily C member 6 | Soms (5–29%) | In 1 aandoening |
| ACAT1acetyl-CoA acetyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| AGGF1angiogenic factor with G-patch and FHA domains 1 | Soms (5–29%) | In 1 aandoening |
| B4GALT1beta-1,4-galactosyltransferase 1 | Soms (5–29%) | In 1 aandoening |
| BMPR1Abone morphogenetic protein receptor type 1A | Soms (5–29%) | In 1 aandoening |
| CD28CD28 molecule | Soms (5–29%) | In 2 aandoeningen |
| CFTRCF transmembrane conductance regulator | Soms (5–29%) | In 1 aandoening |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Soms (5–29%) | In 2 aandoeningen |
| ENGendoglin | Soms (5–29%) | In 1 aandoening |
| ENPP1ectonucleotide pyrophosphatase/phosphodiesterase 1 | Soms (5–29%) | In 1 aandoening |
| FECHferrochelatase | Soms (5–29%) | In 2 aandoeningen |
| GNAQG protein subunit alpha q | Soms (5–29%) | In 1 aandoening |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Soms (5–29%) | In 1 aandoening |
| JAG1jagged canonical Notch ligand 1 | Soms (5–29%) | In 1 aandoening |
| KCNN4potassium calcium-activated channel subfamily N member 4 | Soms (5–29%) | In 1 aandoening |
| LAMA3laminin subunit alpha 3 | Soms (5–29%) | In 1 aandoening |
| LAMB3laminin subunit beta 3 | Soms (5–29%) | In 1 aandoening |
| LAMC2laminin subunit gamma 2 | Soms (5–29%) | In 1 aandoening |
| LYSTlysosomal trafficking regulator | Soms (5–29%) | In 1 aandoening |
| MOGSmannosyl-oligosaccharide glucosidase | Soms (5–29%) | In 1 aandoening |
| PBX1PBX homeobox 1 | Soms (5–29%) | In 1 aandoening |
| PIEZO1piezo type mechanosensitive ion channel component 1 (Er blood group) | Soms (5–29%) | In 2 aandoeningen |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Soms (5–29%) | In 1 aandoening |
| PMM2phosphomannomutase 2 | Soms (5–29%) | In 1 aandoening |
| RNU7-1RNA, U7 small nuclear 1 | Soms (5–29%) | In 1 aandoening |
| RYR1ryanodine receptor 1 | Soms (5–29%) | In 1 aandoening |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Soms (5–29%) | In 1 aandoening |
| SMAD4SMAD family member 4 | Soms (5–29%) | In 1 aandoening |
| TNFRSF1BTNF receptor superfamily member 1B | Soms (5–29%) | In 2 aandoeningen |
| UBR1ubiquitin protein ligase E3 component n-recognin 1 | Soms (5–29%) | In 1 aandoening |
| ZNFX1zinc finger NFX1-type containing 1 | Soms (5–29%) | In 1 aandoening |
| ACBD6acyl-CoA binding domain containing 6 | Zelden (1–4%) | In 1 aandoening |
| ALG12ALG12 alpha-1,6-mannosyltransferase | Zelden (1–4%) | In 2 aandoeningen |
| DUOX2dual oxidase 2 | Zelden (1–4%) | In 1 aandoening |
| GATA1GATA binding protein 1 | Zelden (1–4%) | In 1 aandoening |
| POLGDNA polymerase gamma, catalytic subunit | Zelden (1–4%) | In 1 aandoening |
| POLG2DNA polymerase gamma 2, accessory subunit | Zelden (1–4%) | In 1 aandoening |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Zelden (1–4%) | In 1 aandoening |
| SLC25A4solute carrier family 25 member 4 | Zelden (1–4%) | In 1 aandoening |
| TSHRthyroid stimulating hormone receptor | Zelden (1–4%) | In 1 aandoening |
| TWNKtwinkle mtDNA helicase | Zelden (1–4%) | In 1 aandoening |
| URODuroporphyrinogen decarboxylase | Zelden (1–4%) | In 1 aandoening |
| UROSuroporphyrinogen III synthase | Zelden (1–4%) | In 1 aandoening |
| AIPAHR interacting HSP90 co-chaperone | Niet vastgelegd | In 1 aandoening |
| BLTP1bridge-like lipid transfer protein family member 1 | Niet vastgelegd | In 1 aandoening |
| BPTFbromodomain PHD finger transcription factor | Niet vastgelegd | In 1 aandoening |
| BSNDbarttin CLCNK type accessory subunit beta | Niet vastgelegd | In 1 aandoening |
| CHRNA1cholinergic receptor nicotinic alpha 1 subunit | Niet vastgelegd | In 1 aandoening |
| CHRNDcholinergic receptor nicotinic delta subunit | Niet vastgelegd | In 1 aandoening |
| CHRNGcholinergic receptor nicotinic gamma subunit | Niet vastgelegd | In 1 aandoening |
| CLCNKAchloride voltage-gated channel Ka | Niet vastgelegd | In 1 aandoening |
| CLCNKBchloride voltage-gated channel Kb | Niet vastgelegd | In 1 aandoening |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Niet vastgelegd | In 1 aandoening |
| EBPEBP cholestenol delta-isomerase | Niet vastgelegd | In 1 aandoening |
| EPHB4EPH receptor B4 | Niet vastgelegd | In 1 aandoening |
| ERBB3erb-b2 receptor tyrosine kinase 3 | Niet vastgelegd | In 1 aandoening |
| ERCC5ERCC excision repair 5, endonuclease | Niet vastgelegd | In 1 aandoening |
| FGAfibrinogen alpha chain | Niet vastgelegd | In 1 aandoening |
| GBE11,4-alpha-glucan branching enzyme 1 | Niet vastgelegd | In 1 aandoening |
| GLE1GLE1 RNA export mediator | Niet vastgelegd | In 1 aandoening |
| IL6interleukin 6 | Niet vastgelegd | In 1 aandoening |
| INPPL1inositol polyphosphate phosphatase like 1 | Niet vastgelegd | In 1 aandoening |
| KITKIT proto-oncogene, receptor tyrosine kinase | Niet vastgelegd | In 1 aandoening |
| KRT13keratin 13 | Niet vastgelegd | In 1 aandoening |
| LAMB2laminin subunit beta 2 | Niet vastgelegd | In 1 aandoening |
| MKKSMKKS centrosomal shuttling protein | Niet vastgelegd | In 1 aandoening |
| MRPS22mitochondrial ribosomal protein S22 | Niet vastgelegd | In 1 aandoening |
| NR2E3nuclear receptor subfamily 2 group E member 3 | Niet vastgelegd | In 1 aandoening |
| NRASNRAS proto-oncogene, GTPase | Niet vastgelegd | In 1 aandoening |
| OSGEPO-sialoglycoprotein endopeptidase | Niet vastgelegd | In 1 aandoening |
| PLD1phospholipase D1 | Niet vastgelegd | In 1 aandoening |
| SGPL1sphingosine-1-phosphate lyase 1 | Niet vastgelegd | In 1 aandoening |
| SLC26A2solute carrier family 26 member 2 | Niet vastgelegd | In 1 aandoening |
| TREX1three prime repair exonuclease 1 | Niet vastgelegd | In 1 aandoening |
| USP8ubiquitin specific peptidase 8 | Niet vastgelegd | In 1 aandoening |
| ZNHIT3zinc finger HIT-type containing 3 | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Smallere kenmerken
- Fluid around lungs86 genen
- Swelling caused by excess lymph fluid under skin75 genen
- Hydrops fetalis71 genen
- Increased nuchal translucency66 genen
- Fluid accumulation in lower limbs53 genen
- Joint swelling53 genen
- Facial puffiness35 genen
- Brain swelling32 genen
- Excess fluid in lungs30 genen
- Generalized edema18 genen
- Edema of the dorsum of hands16 genen
- Angioedema13 genen
- Corneal stromal edema13 genen
- Peripheral edema11 genen
- Laryngeal edema5 genen
- Fetal skin edema4 genen
- Genital edema4 genen
- Peau d'orange4 genen
- Throat swelling3 genen
- Intestinal edema2 genen
- Tongue edema2 genen
- Hyperkeratosis over edematous areas1 gen
- Hypoproteinemic edema1 gen
- Muscular edema1 gen
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken